SAN JOSE, Calif. (KGO) -- A Silicon Valley energy company is expanding COVID test lab capacity in hopes it could speed up the return of businesses and schools to normal. Health is a vital part of Building A Better Bay Area.
This $1.5 million laboratory represents a unique private-public partnership to add virus testing capability in the Bay Area.
"This economy simply cannot wait for months to get back, so we think it's really essential," said KR Sridhar, Bloom Energy CEO.
RELATED: Coronavirus Crisis: Silicon Valley green energy leader answers Gov. Newsom's call to action on ventilators
Even with the promise of vaccines, Bloom Energy believes this lab will accelerate the ability for Bay Area companies, schools and universities to return to normal. Using a system developed by the University of Illinois Urbana Champaign, it can process 10,000 tests per day with same-day results, using a proprietary saliva test.
"Every private citizen, every private organization needs to step in and say, how can I help?" said Sridhar.
The University of Illinois system has been doing routine testing on its campus of 50,000 with one million tests performed.
RELATED: UC Berkeley launches new lab dedicated to test, detect Bay Area wastewater for COVID-19
"I like to think of crushing this virus," said Dr. Timothy Killeen, president of the University of Illinois System. "You don't just watch it and monitor it. But you have to step in to make sure that it doesn't transmit, and that's when minutes count."
Bloom Energy is inviting CEO's across the region to take advantage of its lab. The projected cost is $35 per test. El Camino Health is a partner, bringing its clinical and diagnostic skills to the effort.
"The earlier you can identify a positive case, the earlier you can intervene and quarantine and stop the spread of the virus," said Dan Woods, CEO of El Camino Health.
For every six tests performed, one will be donated to Gardner Health Services, which is trying to reduce double-digit infection rates in east San Jose. Each Wednesday it has the capacity to test 1,000 patients, but it could only do 743 this week due to limited county lab capacity. It turned away 96 patients whose unknown status could spread COVID-19.
RELATED: Santa Clara Co. announces new COVID-19 vaccine allotment; here's who's 1st in line
Another company, Boston based Ginkgo Bioworks, is also building a lab. Its new Emeryville facility, scheduled to be operational by the end of January, will add testing capacity of 10,000 tests per day.
"Having a more local facility to process the collected samples in the area gives us a quicker turnaround time," said Ena Cratsenburg, chief business officer at Ginkgo Bioworks.
Bloom Energy has more details for employers and schools by clicking here.
If you have a question or comment about the COVID-19 vaccine, submit via the form below or here.
RELATED STORIES & VIDEOS:
- Map: CA counties that can, can't reopen under new rules
- COVID-19 risk calculator: The safest and most dangerous things to do this holiday season
- Updated number of COVID-19 deaths, cases in Bay Area
- COVID-19 Help: Comprehensive list of resources, information
- California EDD: The most commonly asked questions we get about unemployment and PUA
- Health experts urge flu shots in effort to avoid 'twindemic'
- How to tell the difference between seasonal allergies and coronavirus symptoms
- Here's which mask is better to protect from COVID-19
- First COVID-19 vaccine volunteers in US describe experience as Bay Area launches vaccine trials
- From salons to dinner parties: Experts rate the risk of 12 activities
- Coronavirus origin: Where did COVID-19 come from?
- What is a COVID-19 genetic, antigen and antibody test?
- What will it take to get a COVID-19 vaccine and how will it be made?
- What does COVID-19 do to your body and why does it spread so easily?
- Here's how shelter in place, stay at home orders can slow spread of COVID-19
- Coronavirus Timeline: Tracking major moments of COVID-19 pandemic in San Francisco Bay Area
- COVID-19 Diaries: Personal stories of Bay Area residents during novel coronavirus pandemic
- Coronavirus Doctor's Note: Dr. Alok Patel gives his insight into COVID-19 pandemic